Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04522895
Title IDH2-Post-Allo-Trial for Patients With IDH2-mut Myeloid Neoplasms After Allo-SCT
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Heinrich-Heine University, Duesseldorf
Indications

acute myeloid leukemia

chronic myelomonocytic leukemia

myelodysplastic syndrome

Therapies

Enasidenib

Age Groups: senior | adult
Covered Countries DEU

Additional content available in CKB BOOST